2011
DOI: 10.1097/01.asw.0000395038.28398.88
|View full text |Cite
|
Sign up to set email alerts
|

Retrospective Comparison of Diabetic Foot Ulcer and Venous Stasis Ulcer Healing Outcome Between a Dermal Repair Scaffold (PriMatrix) and a Bilayered Living Cell Therapy (Apligraf)

Abstract: Although both treatments were highly effective, the study results of 68 ulcers in 48 patients demonstrated that patients treated with PriMatrix healed faster than patients treated with Apligraf despite larger wound sizes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(14 citation statements)
references
References 25 publications
(20 reference statements)
0
14
0
Order By: Relevance
“…In contrast, the intact collagen is resistant to lymphocyte action and is retained longer in the wound bed acting as an exogenous matrix (55). Another shortcoming of fractionated and subsequently cross-linked collagen is its densely packed structure that prevents penetration of fibroblasts and their interaction with the collagen matrix (56).…”
Section: Collagenbased Medical Devices and Productsmentioning
confidence: 99%
“…In contrast, the intact collagen is resistant to lymphocyte action and is retained longer in the wound bed acting as an exogenous matrix (55). Another shortcoming of fractionated and subsequently cross-linked collagen is its densely packed structure that prevents penetration of fibroblasts and their interaction with the collagen matrix (56).…”
Section: Collagenbased Medical Devices and Productsmentioning
confidence: 99%
“…Both terminally differentiated dermal cells and stem cells have been used extensively in skin and hair follicle regeneration. The FDA-approved product Apligraf (Organogenesis, Canton, MA, http://www.organogenesis.com) consists of dermal fibroblasts seeded onto collagen type I and overlaid by keratinocytes and showed promising results in clinical trials for treatment of chronic skin wounds associated with diabetes [81]. Many current efforts also use HFP and bulge cells (Fig.…”
Section: Dscs In Tissue Engineering and Regenerative Medicinementioning
confidence: 99%
“…It is FDA approved for chronic wound conditions like venous leg ulcers and diabetic foot ulcers [69]. However it is an allogeneic product and is prone to immune-mediated rejection.…”
Section: Therapeutic Indicationsmentioning
confidence: 99%